Background: During storage of red blood cell (RBC) concentrates, the plasticizer di-2-ethylhexylphthalate (DEHP) that keeps the blood bags soft leaches out and can be taken up by the RBCs. DEHP is known to be beneficial for the RBC storage quality, but the molecular mechanisms of the action are unknown. Methods: Aqueous suspensions of DEHP were added to RBCs in buffer. The morphological effects were observed on RBCs from 5 donors. Flow cytometry with annexin A5 binding was used to measure the exposed phosphatidylserine. Results: DEHP induced the formation of stomatocytes at concentrations as low as ng/ml, provided that the cell suspension was also sufficiently dilute. Some spherocytes, which were susceptible to lysis, were also formed; after lysis, RBC ghosts were seen to continue the transition to the cup-shaped stomatocyte form. Incubation with DEHP increased the exposed phosphatidylserine, an effect that was also observed in the presence of vanadate, which inhibits the ATP-dependent translocases that maintain the membrane's lipid asymmetry. Conclusions: DEHP can have an active effect on RBC shape, instead of just preventing the storage-related shape changes. The effect appears to be mediated by increased flip-flop of lipids between the leaflets of the RBC membrane.

Keywords:
Storage, Erythrocytes, Plasticizer, Di-Ethylhexylphthalate, Lipid bilayers
1.
Rahman M, Brazel, CS: The plasticizer market: an assessment of traditional plasticizers and research trends to meet new challenges. Prog Polym Sci 2004;29:1223-1248.
2.
Jaeger RJ, Rubin RJ: Plasticizers from plastic devices: extraction, metabolism, and accumulation by biological systems. Science 1970;170:450-451.
3.
Rock G, Labow RS, Tocchi M: Distribution of Di(2-ethylhexyl) phthalate and products in blood and blood components. Environ Health Perspect 1986;65:309-316.
4.
Sampson J, de Korte D: DEHP-plasticised PVC: relevance to blood services. Transfus Med 2011;21:273-283.
5.
Koch HM, Rossbach B, Drexler H, Angerer J: Internal exposure of the general population to DEHP and other phthalates- determination of secondary and primary phthalate monoester metabolites in urine. Environ Res 2003;93:177-185.
6.
Parks LG, Ostby JS, Lambright CR, Abbott BD, Klinefelter GR, Barlow NJ, Gray, LE: The plasticiser diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci 2000;58:339-349.
7.
Blystone CR, Kissling GE, Bishop JB, Chapin JR, Wolfe GW, Foster PMD: Determination of the di(2-ethylhexl) phthalate NOAEL for reproductive development in the rat: importance of the retention of extra animals to adulthood. Toxicol Sci 2010;116:640-646.
8.
AuBuchon JP, Estep TN, Davey RJ: The effect of the plasticizer di-2-ethylhexyl phthalate on the survival of stored RBCs. Blood 1988;71:448-452.
9.
Bicalho B, Serrano K, dos Santos Pereira A, Devine DV, Acker JP: Blood bag plasticizers influence red blood cell vesiculation rate without altering the lipid composition of the vesicles. Transfus Med Hemother 2016;43:19-26.
10.
Estep TN, Pedersen RA, Miller TJ, Stupar KR: Characterization of erythrocyte quality during the refrigerated storage of whole blood containing di-(2-ethylhexyl) phthalate. Blood 1984;64:1270-1276.
11.
Serrano K, Levin E, Chen D, Hansen A, Turner TR, Kurach J, Reidel A, Boecker WF, Acker JP, Devine DV: An investigation of red blood cell concentrate quality during storage in paediatric-sized polyvinylchloride bags plasticized with alternatives to di-2-ethylhexyl phthalate (DEHP). Vox Sang 2015;110:227-235.
12.
Hill HR, Oliver CK, Lippert LE, Greenwalt TJ, Hess JR: The effects of polyvinyl chloride and polyolefin blood bags on red blood cells stored in a new additive solution. Vox Sang 2001;81:161-166.
13.
Nakao M, Nakao T, Yamazoe S: Adenosine triphosphate and maintenance of shape of the human red cells. Nature 1960;187:945-946.
14.
Seigneuret M, Devaux PF: ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci U SA 1984;81;3751-3755.
15.
Devaux PF, Herrmann A, Ohlwein N, Kozlov MM: How lipid flippases can modulate membrane structure. Biochim Biophys Acta 2008;1778:1591-1600.
16.
Ferrell JE, Huestis WH: Phosphoinositide metabolism and the morphology of human erythrocytes. J Cell Biol 1984;98:1992-1998.
17.
Sheetz MP, Singer SJ: Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci U S A 1974;71:4457-4461.
18.
Mukhopadhyay R, Lim G, Wortis M: Echinocyte shapes: bending, stretching and shear determine spicule shape and spacing. Biophys J 2002;82:1756-1772.
19.
Melzak KA, Lazaro GR, Hernandez-Machado A, Pagonabarraga I, de Espada JCMD, Toca-Herrera JL: AFM measurements and lipid rearrangements: evidence from red blood cell shape changes. Soft Matter 2012;8:7716-7726.
20.
Zachowski A: Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J 1993;294:1-14.
21.
Wong P: A basis of echinocytosis and stomatocytosis in the disc-sphere transformations of the erythrocyte. J Theor Biol 1999;196:343-361.
22.
Jay AWL: Geometry of the human erythrocyte I. Effect of albumin on cell geometry. Biophys J 1975;15:205-222.
23.
Reinhart WH, Chien S: Echinocyte-stomatocyte transformation and shape control of human red blood cells; morphological aspects. Am J Hematol 1987;24;1-14.
24.
Stewart A, Urbaniak S, Turner M, Bessos H: The application of a new quantitative assay for the monitoring of integrin-associated protein CD47 on red blood cells during storage and comparison with the expression of CD47 and phosphatidylserine with flow cytometry. Transfusion 2005;45:1496-1503.
25.
Bain BJ: Blood Cells - a Practical Guide, ed 2. Oxford, Blackwell Science, 1995.
26.
Daleke DL, Huestis WH: Incorporation and translocation of aminophopholipids in human erythrocytes. Biochemistry 1985;24;5406-5416.
27.
Dodge JT, Phillips GB: Composition of phospholipids and of phospholipid fatty acids and aldehydes in human red cells. J Lipid Res 1967;8:667-675.
28.
Bosch FH, Werre JM, Roerdinkholder-Stoelwinder B, Huls TH, Willekens FLA, Halie MR: Characteristics of red blood cell populations fractionated with a combination of counterflow centrifugation and Percoll centrifugation. Blood 1992;79:254-260.
29.
Draper CJ, Greenwalt TJ, Dumaswala UJ: Biochemical and structural changes in RBCs stored with different plasticizers: the role of hexanol. Transfusion 2002;42:830-835.
30.
Högman CF, Meryman HT: Storage parameters affecting red blood cell survival and function after transfusion. Transfus Med Rev 1999;13:275-296.
31.
Deuticke B: Transformation and restoration of biconcave shape of human erythrocytes induced by amphiphilic agents and changes of ionic environment. Biochim Biophys Acta 1968;163;494-500.
32.
Vlaar APJ, Kulik W, Nieuwland R, Peters CP, Tool ATJ, van Bruggen R, Juffermans NP, de Korte D: Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion 2011;51:2358-2366.
33.
Truong HTN, Daleke DL, Huestis WH: Human erythrocyte shape regulation: interaction of metabolic and redox status. Biochim Biophys Acta 1993;1150:51-56.
34.
Khairy K, Foo J, Howard J: Shapes of red blood cells: comparison of 3D confocal images with the bilayer-couple model. Cell Mol Bioeng 2008;1:173-181.
35.
Tyteca D, D'Auria L, Van Der Smissen P, Medts T, Carpentier S, Monbaliu JC, de Diesbach P, Courtoy PL: Three unrelated sphingomyelin analogs spontaneously cluster into plasma membrane micrometric domains. Biochim Biophys Acta 2010;1798:909-927.
36.
Melzak KA, Janzen J, Brooks DE: Electrostatic effects on the adsorption and carbodiimide-mediated coupling of ferrichrome A to amine-modified silica. J Coll Interface Sci 1995;174:480-489.
37.
Sackmann E, Feder T: Budding, fission and domain formation in mixed lipid vesicle induced by lateral phase separation and macromolecular condensation. Mol Membr Biol 1995;12:21-28.
38.
European Chemicals Bureau, Institute for Health and Consumer Protection (Joint Research Centre), Toxicology and Chemical Substances: Summary risk assessment report bis (2-ethylhexyl) phthalate (DEHP). https://publications.europa.eu/en/publication-detail/-/publication/322f90a7-4766-4b8c-8d2f-564e32ae7199/language-en (last accessed October 11, 2018).
39.
Bonora S, Fini G, Piccirilli B: DSC study on the interaction between bis-2-(ethylhexyl) phthalate and other o-phthalic acid esters and dipalmitoyl phosphatidylcholine liposomes. J Therm Anal Cal.2000;61:731-743.
40.
Wolkers WF, Crowe LM, Tsvetkova NM, Tablin F, Crowe JH: In situ assessment of erythrocyte membrane properties during cold storage. Mol Membr Biol 2002;19:59-65.
41.
Lim G, Wortis M, Mukhopadhyay R: Stomatocyte-discocyte-echinocyte sequence of the human red blood cell: evidence for the bilayer-couple hypothesis from membrane mechanics Proc Natl Acad Sci U S A 2002;99;16766-16769.
42.
Ran Q, Xiang Y, Liu Y, Xiang LX, Li FJ, Deng XJ, Xiao YN, Chen L, Chen LL, Li ZJ: Eryptosis indices as a novel predictive parameter for biocompatibility of Fe3O4 magnetic nanoparticles on erythrocytes. Sci Rep 2015;5:16209.
43.
Boon JM, Smith BD: Facilitated phosphatidylcholine flip-flop across erythrocyte membrane using low molecular weight synthetic translocases. J Am Chem Soc 2001;123:6221-6226.
44.
Boon JM, Lambert TN, Sisson AL, Davis AP, Smith BD: Facilitated phosphatidylserine (PS) flip-flop and thrombin activation using a synthetic scramblase. J Am Chem Soc 2003;125:8195-8201.
45.
Roussel C, Dussiot M, Marin M, Morel A, Ndour PA, Duez, J, Le Van Kim C, Hermine O, Colin Y, Buffet PA, Amireault P.:Spherocytic shift of red blood cells during storage provides a quantitative whole cell-based marker of the storage lesion. Transfusion 2017;57:1007-1018.
46.
Lu J, Shi H, Yu H, Hou J, Zhou J: Procoagulant activity of long-term stored red blood cells due to phosphatidylserine exposure. Transfus Med 2011;21:150-157.
© 2018 S. Karger GmbH, Freiburg
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.